Silencing of insulin receptor substrate-1 increases cell death in retinal müller cells

Molecular Vision

Volumn 18, Issue , 2012, Pages 271-279

  Walker, Robert J ^a   Anderson, Nancy M ^a   Bahouth, Suleiman ^a   Steinle, Jena J ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR; CYTOCHROME C; INSULIN RECEPTOR SUBSTRATE 1; PROTEIN BAX; PROTEIN BCL XL;

ANIMAL CELL; ANIMAL CELL CULTURE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; MUELLER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ADRENERGIC BETA-2 RECEPTOR AGONISTS; ALBUTEROL; ANIMALS; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; BLOTTING, WESTERN; CELL DEATH; CYTOCHROMES C; GENE EXPRESSION REGULATION; GENE SILENCING; GLUCOSE; HUMANS; INSULIN RECEPTOR SUBSTRATE PROTEINS; NEUROGLIA; PHOSPHORYLATION; RATS; RECEPTORS, ADRENERGIC, BETA-2; RETINA; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84856785402     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Klein R. Diabetic retinopathy. Annu Rev Public Health 1996; 17:137-58.[PMID: 8724221]
2. Abu-El-Asrar AM, Dralands L, Missotten L, Al-Jadaan IA, Geboes K. Expression of apoptosis markers in the retinas of human subjects with diabetes. Invest Ophthalmol Vis Sci 2004; 45:2760-6.[PMID: 15277502]
3. Frank RN. Diabetic retinopathy. N Engl J Med 2004; 350:48-58.[PMID: 14702427]
4. Kondo T, Kahn CR. Altered insulin signaling in retinal tissue in diabetic states. J Biol Chem 2004; 279:37997-8006.[PMID: 15201286]
5. Bringmann A, Pannicke T, Grosche J, Francke M, Wiedemann P, Skatchkov SN, Osborne NN, Reichenbach A. Muller cells in the healthy and diseased retina. Prog Retin Eye Res 2006; 25:397-424.[PMID: 16839797]
6. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 444:860-7.[PMID: 17167474]
7. Joussen AM, Doehmen S, Le ML, Koizumi K, Radetzky S, Krohne TU, Poulaki V, Semkova I, Kociok N. TNF-alpha mediated apoptosis plays an important role in the development of early diabetic retinopathy and long-term histopathological alterations. Mol Vis 2009; 15:1418-28. [PMID: 19641635]
8. Mysona B, Dun Y, Duplantier J, Ganapathy V, Smith S. Effects of hyperglycemia and oxidative stress on the glutamate transporters GLAST and system xc- in mouse retinal Müller glial cells. Cell Tissue Res 2009; 335:477-88. [PMID: 19156441]
9. Tret'iak EB, Syroedova ON, Neuhaus O, Andreeva AV, Antsiferov MB, Mkrtumian AM, Suchkov SV. Cytokines and their role in pathogenesis of diabetic retinopathy. Vestn Oftalmol 2010; 126:53-7.[PMID: 21395004]
10. Trudeau K, Molina AJ, Guo W, Roy S. High glucose disrupts mitochondrial morphology in retinal endothelial cells: implications for diabetic retinopathy. Am J Pathol 2010; 177:447-55.[PMID: 20522647]
11. Curtis TM, Hamilton R, Yong PH, McVicar CM, Berner A, Pringle R, Uchida K, Nagai R, Brockbank S, Stitt AW. Müller glial dysfunction during diabetic retinopathy in rats is linked to accumulation of advanced glycation end-products and advanced lipoxidation end-products. Diabetologia 2011; 54:690-8.[PMID: 21116609]
12. Mizutani M, Gerhardinger C, Lorenzi M. Muller cell changes in human diabetic retinopathy. Diabetes 1998; 47:445-9.[PMID: 9519752]
13. King JL, Guidry C. Muller cell production of insulin-like growth factor-binding proteins in vitro: modulation with phenotype and growth factor stimulation. Invest Ophthalmol Vis Sci 2004; 45:4535-42.[PMID: 15557465]
14. Kusner LL, Sarthy VP, Mohr S. Nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase: a role in high glucose-induced apoptosis in retinal Muller cells. Invest Ophthalmol Vis Sci 2004; 45:1553-61.[PMID: 15111614]
15. Guidry C, King JL, Mason JO 3rd. Fibrocontractive Müller cell phenotypes in proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 2009; 50:1929-39.[PMID: 19117921]
16. Fletcher EL, Phipps JA, Ward MM, Puthussery T, Wilkinson-Berka JL. Neuronal and glial cell abnormality as predictors of progression of diabetic retinopathy. Curr Pharm Des 2007; 13:2699-712.[PMID: 17897014]
17. Li Q, Puro DG. Diabetes-induced dysfunction of the glutamate transporter in retinal Muller cells. Invest Ophthalmol Vis Sci 2002; 43:3109-16.[PMID: 12202536]
18. Kowluru RA, Tang J, Kern TS. Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. Diabetes 2001; 50:1938-42.[PMID: 11473058]
19. Aguirre V, Werner ED, Giraud J, Lee YH, Shoelson SE, White MF. Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J Biol Chem 2002; 277:1531-7.[PMID: 11606564]
20. Greene MW, Garofalo RS. Positive and Negative Regulatory Role of Insulin Receptor Substrate 1 and 2 (IRS-1 and IRS-2) Serine/Threonine Phosphorylation. Biochemistry 2002; 41:7082-91.[PMID: 12033942]
21. Hartman ME, Villela-Bach M, Chen J, Freund GG. FRAPDependent Serine Phosphorylation of IRS-1 Inhibits IRS-1 Tyrosine Phosphorylation. Biochem Biophys Res Commun 2001; 280:776-81.[PMID: 11162588]
22. Luo M, Langlais P, Yi Z, Lefort N, De Filippis EA, Hwang H, Christ-Roberts CY, Mandarino LJ. Phosphorylation of human insulin receptor substrate-1 at Serine 629 plays a positive role in insulin signaling. Endocrinology 2007; 148:4895-905.[PMID: 17640984]
23. Luo M, Reyna S, Wang L, Yi Z, Carroll C, Dong LQ, Langlais P, Weintraub ST, Mandarino LJ. Identification of insulin receptor substrate 1 serine/threonine phosphorylation sites using mass spectrometry analysis: regulatory role of serine 1223. Endocrinology 2005; 146:4410-6.[PMID: 16020478]
24. Aguirre V, Uchida T, Yenush L, Davis R, White MF. The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem 2000; 275:9047-54.[PMID: 10722755]
25. Boura-Halfon S, Zick Y. Phosphorylation of IRS proteins, insulin action, and insulin resistance. Am J Physiol Endocrinol Metab 2009; 296:E581-91.[PMID: 18728222]
26. Hotamisligil GS, Budavari A, Murray D, Spiegelman BM. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. J Clin Invest 1994; 94:1543-9.[PMID: 7523453]
27. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesityinduced insulin resistance. Science 1996; 271:665-8.[PMID: 8571133]
28. Paz K, Hemi R, LeRoith D, Karasik A, Elhanany E, Kanety H, Zick Y. A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. J Biol Chem 1997; 272:29911-8. [PMID: 9368067]
29. Paz K, Liu YF, Shorer H, Hemi R, LeRoith D, Quan M, Kanety H, Seger R, Zick Y. Phosphorylation of insulin receptor substrate-1 (IRS-1) by protein kinase B positively regulates IRS-1 function. J Biol Chem 1999; 274:28816-22.[PMID: 10497255]
30. Sykiotis GP, Papavassiliou AG. Serine phosphorylation of insulin receptor substrate-1: a novel target for the reversal of insulin resistance. Mol Endocrinol 2001; 15:1864-9.[PMID: 11682617]
31. White MF. IRS proteins and the common path to diabetes. Am J Physiol Endocrinol Metab 2002; 283:E413-22.[PMID: 12169433]
32. Kowluru RA. Diabetic Retinopathy: Mitochondrial Dysfunction and Retinal Capillary Cell Death. Antioxid Redox Signal 2005; 7:1581.[PMID: 16356121]
33. Kowluru RA, Kennedy A. Therapeutic potential of antioxidants and diabetic retinopathy. Expert Opin Investig Drugs 2001; 10:1665-76.[PMID: 11772276]
34. Hasnan J, Yusof MI, Damitri TD, Faridah AR, Adenan AS, Norbaini TH. Relationship between apoptotic markers (Bax and Bcl-2) and biochemical markers in type 2 diabetes mellitus. Singapore Med J 2010; 51:50-5.[PMID: 20200776]
35. Hetz C. BCL-2 protein family. Essential regulators of cell death. Preface. Adv Exp Med Biol 2010; 687:vii-viii.[PMID: 20919634]Introductory
36. Khalfaoui T, Basora N, Ouertani-Meddeb A. Apoptotic factors (Bcl-2 and Bax) and diabetic retinopathy in type 2 diabetes. J Mol Histol 2010; 41:143-52.[PMID: 20532811]
37. Soriano ME, Scorrano L. The interplay between BCL-2 family proteins and mitochondrial morphology in the regulation of apoptosis. Adv Exp Med Biol 2010; 687:97-114.[PMID: 20919640]
38. Lindsay J, Esposti MD, Gilmore AP. Bcl-2 proteins and mitochondria-specificity in membrane targeting for death. Biochim Biophys Acta 2011; 1813:532-9.[PMID: 21056595]Review
39. Zhou F, Yang Y, Xing D. Bcl-2 and Bcl-xL play important roles in the crosstalk between autophagy and apoptosis. FEBS J 2011; 278:403-13.[PMID: 21182587]
40. Walker RJ, Steinle J. Role of Beta-adrenergic Receptors in Inflammatory Marker Expression in Muller Cells. Invest Ophthalmol Vis Sci 2007; 48:5276-81.[PMID: 17962483]
41. Kern TS, Du Y, Miller CM, Hatala DA, Levin LA. Overexpression of Bcl-2 in vascular endothelium inhibits the microvascular lesions of diabetic retinopathy. Am J Pathol 2010; 176:2550-8.[PMID: 20363911]
42. Ueno H, Kondo E, Yamamoto-Honda R, Tobe K, Nakamoto T, Sasaki K, Mitani K, Furusaka A, Tanaka T, Tsujimoto Y, Kadowaki T, Hirai H. Association of insulin receptor substrate proteins with Bcl-2 and their effects on its phosphorylation and antiapoptotic function. Mol Biol Cell 2000; 11:735-46.[PMID: 10679027]
43. Baltensperger K, Karoor V, Paul H, Ruoho A, Czech MP, Malbon CC. The beta-adrenergic receptor is a substrate for the insulin receptor tyrosine kinase. J Biol Chem 1996; 271:1061-4.[PMID: 8557631]
44. Reiter CE, Sandirasegarane L, Wolpert EB, Klinger M, Simpson IA, Barber AJ, Antonetti DA, Kester M, Gardner TW. Characterization of insulin signaling in rat retina in vivo and ex vivo. Am J Physiol Endocrinol Metab 2003; 285:E763-74.[PMID: 12799319]
45. Reiter CE, Wu X, Sandirasegarane L, Nakamura M, Gilbert KA, Singh RS, Fort PE, Antonetti DA, Gardner TW. Diabetes Reduces Basal Retinal Insulin Receptor Signaling. Diabetes 2006; 55:1148-56.[PMID: 16567541]
46. Valverde AM, Mur C, Pons S, Alvarez AM, White MF, Kahn CR, Benito M. Association of insulin receptor substrate 1 (IRS-1) y895 with Grb-2 mediates the insulin signaling involved in IRS-1-deficient brown adipocyte mitogenesis. Mol Cell Biol 2001; 21:2269-80. [PMID: 11259577]
47. Withers DJ, White M. Perspective: The insulin signaling system-a common link in the pathogenesis of type 2 diabetes. Endocrinology 2000; 141:1917-21.[PMID: 10830270]
48. Taniguchi CM, Emanuelli B, Kahn CR. Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol 2006; 7:85-96.[PMID: 16493415]
49. Lorenzo M, Fernandez-Veledo S, Vila-Bedmar R, Garcia- Guerra L, De Alvaro C, Nieto-Vazquez I. Insulin resistance induced by tumor necrosis factor-alpha in myocytes and brown adipocytes. J Anim Sci 2008; 86:E94-104.[PMID: 17940160]
50. Panjala SR, Steinle J. Insulin and β-adrenergic Receptors Inhibit Retinal Endothelial Cell Apoptosis Through Independent Pathways. Neurochem Res 2011; 36:604-12.[PMID: 21053068]